1. Home
  2. Analysis
  3. Cipro
  4. Zytiga

Cipro and Zytiga drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cipro (ciprofloxacin hydrochloride) and Zytiga (abiraterone acetate). Common drug interactions include death among males.

The phase IV clinical study analyzes what interactions people have when they take Cipro and Zytiga. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.

What is Zytiga?

Zytiga has active ingredients of abiraterone acetate. It is often used in prostate cancer metastatic. eHealthMe is studying from 29,928 Zytiga users. Check the latest studies of Zytiga.

On Jul, 19, 2026

20 people who take Cipro and Zytiga together, and have interactions are studied.

Cipro and Zytiga drug interactions.

What are the common drug interactions of Cipro and Zytiga, by gender? *:

female:

n/a

male:

  1. Death
  2. Decreased appetite
  3. Bladder dilatation
  4. Bladder outlet obstruction (urological condition where the urine flow from the urinary bladder through the urethra is impeded)
  5. Bone pain
  6. Calculus bladder (bladder stone)
  7. Cardiac failure congestive
  8. Constipation
  9. Contusion (a type of hematoma of tissue in which capillaries)
  10. Dehydration (dryness resulting from the removal of water)

What are the common drug interactions of Cipro and Zytiga, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Death
  2. Constipation
  3. Contusion (a type of hematoma of tissue in which capillaries)
  4. Hospitalisation
  5. Platelet count decreased
  6. Swelling

60+:

  1. Death
  2. Decreased appetite
  3. Dysuria (painful or difficult urination)
  4. Fatigue (feeling of tiredness)
  5. Gingival disorder (gum disease)
  6. Haematuria (presence of blood in urine)
  7. Hospitalisation
  8. Hydronephrosis (water inside the kidney)
  9. Hypoaesthesia (reduced sense of touch or sensation)
  10. Hypotension (abnormally low blood pressure)

What are the existing conditions these people have? *

  1. Prostate Cancer: 12 people, 60.00%
  2. Neoplasm Malignant (cancer tumour): 3 people, 15.00%
  3. Hypokalemia (low potassium): 2 people, 10.00%
  4. Nausea (feeling of having an urge to vomit): 2 people, 10.00%
  5. Thrombocytopenia (decrease of platelets in blood): 1 person, 5.00%
  6. Insomnia (sleeplessness): 1 person, 5.00%
  7. Angiopathy (generic term for a disease of the blood vessels): 1 person, 5.00%
  8. Back Pain: 1 person, 5.00%
  9. Bone Pain: 1 person, 5.00%
  10. Constipation: 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Cipro and Zytiga?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cipro and Zytiga:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zytiga:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cipro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zytiga and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ciprofloxacin hydrochloride and abiraterone acetate (the active ingredients of Cipro and Zytiga, respectively), and Cipro and Zytiga (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.